Literature DB >> 18574467

Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.

S Lukasiak1, C Schiller, P Oehlschlaeger, G Schmidtke, P Krause, D F Legler, F Autschbach, P Schirmacher, K Breuhahn, M Groettrup.   

Abstract

The mRNA of the ubiquitin-like modifier FAT10 has been reported to be overexpressed in 90% of hepatocellular carcinoma (HCC) and in over 80% of colon, ovary and uterus carcinomas. Elevated FAT10 expression in malignancies was attributed to transcriptional upregulation upon the loss of p53. Moreover, FAT10 induced chromosome instability in long-term in vitro culture, which led to the hypothesis that FAT10 might be involved in carcinogenesis. In this study we show that interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha synergistically upregulated FAT10 expression in liver and colon cancer cells 10- to 100-fold. Real-time RT-PCR revealed that FAT10 mRNA was significantly overexpressed in 37 of 51 (72%) of human HCC samples and in 8 of 15 (53%) of human colon carcinomas. The FAT10 cDNA sequences in HCC samples were not mutated and intact FAT10 protein was detectable. FAT10 expression in both cancer tissues correlated with expression of the IFN-gamma- and TNF-alpha-dependent proteasome subunit LMP2 strongly suggesting that proinflammatory cytokines caused the joint overexpression of FAT10 and LMP2. NIH3T3 transformation assays revealed that FAT10 had no transforming capability. Taken together, FAT10 qualifies as a marker for an interferon response in HCC and colon carcinoma but is not significantly overexpressed in cancers lacking a proinflammatory environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574467     DOI: 10.1038/onc.2008.201

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  66 in total

1.  Increased expression of FAT10 is correlated with progression and prognosis of human glioma.

Authors:  Jun Yuan; Yanyang Tu; Xinggang Mao; Shiming He; Liang Wang; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  Pathol Oncol Res       Date:  2012-03-09       Impact factor: 3.201

2.  The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Andrew Lin; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-04-28       Impact factor: 3.362

3.  USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Authors:  Annette Aichem; Christiane Pelzer; Sebastian Lukasiak; Birte Kalveram; Paul W Sheppard; Neha Rani; Gunter Schmidtke; Marcus Groettrup
Journal:  Nat Commun       Date:  2010-05-04       Impact factor: 14.919

4.  Falling from grace: HPRT is not suitable as an endogenous control for cancer-related studies.

Authors:  Michelle H Townsend; Abigail M Felsted; Zac E Ence; Stephen R Piccolo; Richard A Robison; Kim L O'Neill
Journal:  Mol Cell Oncol       Date:  2019-02-26

5.  Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis.

Authors:  Yingjie Wu; Pnina Brodt; Hui Sun; Wilson Mejia; Ruslan Novosyadlyy; Nomeli Nunez; Xiaoli Chen; Arnulfo Mendoza; Sung-Hyeok Hong; Chand Khanna; Shoshana Yakar
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

6.  FAT10 protects cardiac myocytes against apoptosis.

Authors:  Xiaogang Peng; Jianghua Shao; Yang Shen; Yunguo Zhou; Qing Cao; Jinzhu Hu; Wenfeng He; Xin Yu; Xiuxia Liu; Ali J Marian; Kui Hong
Journal:  J Mol Cell Cardiol       Date:  2013-02-13       Impact factor: 5.000

7.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

8.  The ubiquitin-like protein FAT10 mediates NF-kappaB activation.

Authors:  Pengfei Gong; Allon Canaan; Bin Wang; Jeremy Leventhal; Alexandra Snyder; Viji Nair; Clemens D Cohen; Matthias Kretzler; Vivette D'Agati; Sherman Weissman; Michael J Ross
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

9.  Dissecting interferon-induced transcriptional programs in human peripheral blood cells.

Authors:  Simon J Waddell; Stephen J Popper; Kathleen H Rubins; Michael J Griffiths; Patrick O Brown; Michael Levin; David A Relman
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

10.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.